Sandoz Group AG
SDZ
Rank in Stocks
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Share Price
$95.99
Market Cap
$41.53B
Change (1 day)
0.79%
Change (1 year)
58.61%
Country
CH
Trade Sandoz Group AG (SDZ)
Category
Healthcare
P/B ratio for Sandoz Group AG (SDZ)
P/B ratio as of 2026 TTM: 0
According to Sandoz Group AG latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Sandoz Group AG from 2020 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2025 | 3.35 | 55.41% |
| 2024 | 2.16 | 13.43% |
| 2023 | 1.90 | -100.00% |
| 2022 | 177.79K | 9,476,858.69% |
| 2021 | 1.88 | -10.92% |
| 2020 | 2.11 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | - |
IN
|
